- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x RIE: (3R,5R)-7-[1-(4-fluorophenyl)-4-(1-methylethyl)-3-{methyl[(1R)-1-phenylethyl]carbamoyl}-1H-pyrazol-5-yl]-3,5-dihydroxyheptanoic acid(Non-covalent)
RIE.2: 22 residues within 4Å:- Chain A: R.156, S.227, V.249, S.250, N.252, D.256, K.257, K.258
- Chain B: E.125, G.126, C.127, L.128, A.130, S.131, R.134, K.301, A.317, H.318, N.321, L.419, A.422, L.423
16 PLIP interactions:9 interactions with chain A, 7 interactions with chain B- Hydrophobic interactions: A:V.249, B:A.130, B:A.422, B:L.423
- Hydrogen bonds: A:R.156, A:R.156, A:S.250, B:E.125, B:S.131, B:N.321
- Water bridges: A:S.250, A:N.252, A:K.257
- Salt bridges: A:R.156, A:K.258, B:K.301
RIE.4: 22 residues within 4Å:- Chain A: E.125, G.126, C.127, L.128, A.130, S.131, R.134, K.301, A.317, H.318, N.321, L.419, A.422, L.423
- Chain B: R.156, S.227, V.249, S.250, N.252, D.256, K.257, K.258
16 PLIP interactions:6 interactions with chain A, 10 interactions with chain B- Hydrophobic interactions: A:A.130, A:A.422, B:V.249
- Hydrogen bonds: A:E.125, A:S.131, A:N.321, B:R.156, B:R.156, B:S.250, B:D.256
- Salt bridges: A:K.301, B:R.156, B:K.258
- Water bridges: B:S.250, B:N.252, B:D.333
RIE.6: 21 residues within 4Å:- Chain C: R.156, S.227, V.249, S.250, N.252, D.256, K.257, K.258
- Chain D: E.125, G.126, C.127, L.128, A.130, S.131, R.134, K.301, A.317, H.318, N.321, L.419, A.422
15 PLIP interactions:6 interactions with chain D, 9 interactions with chain C- Hydrophobic interactions: D:A.130, D:A.422, C:V.249
- Hydrogen bonds: D:E.125, D:S.131, D:N.321, C:R.156, C:R.156, C:S.250
- Salt bridges: D:K.301, C:R.156, C:K.258
- Water bridges: C:S.250, C:N.252, C:K.257
RIE.8: 22 residues within 4Å:- Chain C: E.125, G.126, C.127, L.128, A.130, S.131, R.134, K.301, A.317, H.318, N.321, L.419, A.422, L.423
- Chain D: R.156, S.227, V.249, S.250, N.252, D.256, K.257, K.258
17 PLIP interactions:7 interactions with chain C, 10 interactions with chain D- Hydrophobic interactions: C:A.130, C:A.422, C:L.423, D:V.249
- Hydrogen bonds: C:E.125, C:S.131, C:N.321, D:R.156, D:R.156, D:S.250, D:D.256
- Salt bridges: C:K.301, D:R.156, D:K.258
- Water bridges: D:S.250, D:N.252, D:K.257
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pfefferkorn, J.A. et al., Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. J.Med.Chem. (2008)
- Release Date
- 2008-04-29
- Peptides
- 3-hydroxy-3-methylglutaryl-coenzyme A reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x RIE: (3R,5R)-7-[1-(4-fluorophenyl)-4-(1-methylethyl)-3-{methyl[(1R)-1-phenylethyl]carbamoyl}-1H-pyrazol-5-yl]-3,5-dihydroxyheptanoic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pfefferkorn, J.A. et al., Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. J.Med.Chem. (2008)
- Release Date
- 2008-04-29
- Peptides
- 3-hydroxy-3-methylglutaryl-coenzyme A reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D